May 28, 2020 (Market Insight Reports) -- Selbyville, Delaware — The 2019-2027 report on Global Liquid Biopsy Market explores the essential factors of Liquid Biopsy Market industry covering current scenario, market demand information, coverage of active companies and segmentation forecasts.
The global liquid biopsy market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 21.54%.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/2487064/?utm_source=marketwatch.com&utm_medium=VSD
Factors such as the increase in the number of cancer cases among the aging populace, rise in demand for diagnostic centers, increasing number of government initiatives, rise in use of tissue/tumor-agnostic drugs and wide usage of precision medicine are all significantly contributing to the growth of the liquid biopsy market.
Opportunities like technological advancements and the rise in number of cancer patients can be leveraged by the industry to reach the projected growth. The lack of skilled professionals and the dearth of reimbursements are some of the challenges faced by this market. Also, high cost of tests and a lack of consensus on SOPs, impede the growth of the market.
A liquid biopsy is a non-invasive test used to detect cancer at an early stage and helps in assessing the molecular characteristics of cancer. Liquid biopsy tests help researchers, physicians and surgeons determine an appropriate therapy to improve the life expectancy of cancer patients.
Presently, the APAC liquid biopsy market has highest CAGR, and is the fastest-growing market in the world. There is a probability of major market vendors shifting their sales, manufacturing & distribution facilities to the Asia-Pacific in order to benefit from the attractive proposition of easily available labor, lower cost of land & material and access to a large patient base. The end-users can thus avail the vendors' solutions at extremely low prices. Thus, economic development and growing support from the government, along with a likelihood of major market vendors shifting their operating base to the region, have created new opportunities of the growth of the liquid biopsy market in the Asia-Pacific.
The global liquid biopsy market spans across the regions of North America, Asia-Pacific, Latin America, Europe and the Middle East & Africa.
Becton, Dickinson and Company (BD) is a med-tech corporation, which is involved in improving the quality of life of patients by providing innovative solutions that help develop medical research & genomics, enhance diagnostics, improve medication management, and promote infection prevention. It is a manufacturer and distributor of medical supplies, devices, laboratory equipment, and diagnostic products worldwide. BD is actively involved in the development, manufacturing & distribution of devices, diagnostic products and laboratory equipment over the globe. The company has two subsidiaries: BD Life Sciences and BD Medical. The client base of the company includes life science researchers, healthcare institutes and public & clinical laboratories. It is present in over 50 countries.
The companies that have been mentioned in the global liquid biopsy market report are C. R. Bard, Inc. (acquired by Becton, Dickinson and Company), Fischer Medical Technologies LLC, Cook Medical, Inc., Cardinal Health, Inc., Bio-Rad Laboratories, Inc., Planmeca Oy, Becton, Dickinson, QIAGEN N.V., I.M.S. Internazionale Medico Scientifica Srl, Ad-Tech Medical Instrument Corp., Roche Diagnostics Corporation, Cintec Medical Ltd., B. Braun Melsungen AG, Argon Medical Devices, Boston Scientific Corporation and Agilent Technologies, Inc.
For More Details on this Report: https://www.marketstudyreport.com/reports/global-liquid-biopsy-market-2019-2027?utm_source=marketwatch.com&utm_medium=VSD
Global COVID-19 IgM and IgG Rapid Test Kits Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis.